Skape Bio
Skape Bio is a biotechnology company revolutionizing GPCR drug discovery through AI-powered protein design and high-throughput screening technology. Their innovative platform integrates deep evolutionary insights with advanced methodologies to create novel modulators of integral membrane proteins, enabling the discovery of unique agonists and antagonists. By utilizing in-cell screening, they can evaluate thousands of designs in their natural context, accelerating the development of therapeutics for oncology, inflammation, metabolic disease, and neurology. Skape Bio, a spinout from a collaboration between the BioInnovation Institute and the University of Washington’s Institute for Protein Design, is positioned to lead in the biopharmaceutical space with its cutting-edge technology and partnerships with pharmaceutical companies.
Skape Bio
Skape Bio is a biotechnology company revolutionizing GPCR drug discovery through AI-powered protein design and high-throughput screening technology. Their innovative platform integrates deep evolutionary insights with advanced methodologies to create novel modulators of integral membrane proteins, enabling the discovery of unique agonists and antagonists. By utilizing in-cell screening, they can evaluate thousands of designs in their natural context, accelerating the development of therapeutics for oncology, inflammation, metabolic disease, and neurology. Skape Bio, a spinout from a collaboration between the BioInnovation Institute and the University of Washington’s Institute for Protein Design, is positioned to lead in the biopharmaceutical space with its cutting-edge technology and partnerships with pharmaceutical companies.